Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Targeted Medical Pharma, Inc. (NONE) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Targeted Medical Pharma, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1420030.
Total stock buying since 2014: $350.
Total stock sales since 2014: $203,278.
Total stock option exercises since 2014: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2015 | 0 | $0 | 8,580 | $128 | 0 | $0 |
| 2014 | 700 | $350 | 505,000 | $203,150 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2015-11 | 0 | $0 | 8,580 | $128 | 0 | $0 |
| 2014-11 | 700 | $350 | 0 | $0 | 0 | $0 |
| 2014-08 | 0 | $0 | 101,035 | $40,414 | 0 | $0 |
| 2014-07 | 0 | $0 | 398,965 | $159,586 | 0 | $0 |
| 2014-05 | 0 | $0 | 5,000 | $3,150 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-11-24 | Giffoni Olena B. | Sale | 8,580 | .01 | 128 |
| 2014-11-24 | Giffoni Olena B. | Buy | 700 | .50 | 350 |
| 2014-08-12 | Elizabeth Charuvastra Exemption Trust (CEO & Chief Scientific Officer) | Sale | 101,035 | .40 | 40,414 |
| 2014-07-24 | Elizabeth Charuvastra Exemption Trust (CEO & Chief Scientific Officer) | Sale | 398,965 | .40 | 159,586 |
| 2014-05-28 | Shell William (CEO & Chief Scientific Officer) | Sale | 2,000 | .60 | 1,200 |
| 2014-05-27 | Shell William (CEO & Chief Scientific Officer) | Sale | 3,000 | .65 | 1,950 |
Insider trading activities including stock purchases, stock sales, and option exercises of NONE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Targeted Medical Pharma, Inc. (symbol NONE, CIK number 1420030) see the Securities and Exchange Commission (SEC) website.